Delivery Order SPE2DB20D1050-SPE2DB24FH46J
Award Date
1/11/24
Potential Completion Date
1/12/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,177.78 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of Lacosamide 10 mg/ml solution in 200ml bottles. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range...
The U.S. Defense Logistics Agency (DLA) awarded a $1,565.03 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Lacosamide 10 mg/ml solution in 200 ml vials. This order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025, to deliver a comprehensive range of pharmaceuticals and medical supplies to support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,072.37 for the supply of Lacosamide 10 mg/ml solution. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 22, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,118.64, is for the delivery of Lacosamide 10 mg/ml solution in 200 ml containers. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Lacosamide 10 mg/ml solution, a pharmaceutical product, with a ceiling value of $1,045.92 and a completion date of January 21, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,333.48 firm-fixed-price delivery order is for the supply of Lacosamide 10 mg/ml solution, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,032.18, is a Firm Fixed Price Delivery Order for the supply of Lacosamide 10 mg/ml solution in 200 ml bottles. The contract has an ultimate completion date of January 13, 2025 and was awarded on January 10, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award, valued at $3,996.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Lacosamide 10 mg/ml solution, a pharmaceutical product. It has an ultimate completion date of December 27, 2024. The contract is a Firm Fixed Price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $4,542.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lacosamide 10 mg/ml solution in 200 ml quantities, a pharmaceutical product used for medical treatment. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,720.12 and is for the supply of Lacosamide 10 mg/ml solution in 200 ml containers. The contract has an ultimate completion date of January 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...